Seek Returns

AbbVie (ABBV) Stock Analysis

This is a peer-relative look at AbbVie (ABBV): its performance, risk, profitability, growth, financial strength, dividend, and valuation are each measured against its Pharmaceuticals, Biotechnology & Life Sciences peers, so every number reads in context rather than in isolation.

Company Profile

Company profile fields for AbbVie (ABBV)
Profile ItemABBV
NameAbbVie Inc.
Country/RegionUnited States
GICS SectorHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
GICS Sub-IndustryBiotechnology
Market Capitalization452.48 billion USD
CurrencyUSD
ExchangeNYSE
Listing DateJanuary 2, 2013
Security TypeCommon Stock

Price Performance

Cumulative Growth

ABBV
GSPC
Loading price history…
AbbVie (ABBV) vs. S&P 500 (GSPC): Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for AbbVie (ABBV) and S&P 500 (GSPC). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for AbbVie (ABBV) and S&P 500 (GSPC). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

AbbVie (ABBV) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: ABBVIndustry group median
Total Return (1Y)42.84%47.89%
Total Return (3Y, Annualized)25.49%9.98%
Total Return (5Y, Annualized)21.34%-4.89%

Risk Profile

Drawdown History

ABBV
GSPC
Loading price history…
AbbVie (ABBV) vs. S&P 500 (GSPC): Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for AbbVie (ABBV) and S&P 500 (GSPC). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

AbbVie (ABBV) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: ABBVIndustry group median
Volatility (1Y, Annualized)25.90%69.09%
Beta (5Y)0.300.91
Max Drawdown (5Y)-21.92%-82.64%

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
Each dot is a stock plotted by 1-year volatility (risk) and 1-year return. ABBV is highlighted; the dashed line is the Capital Allocation Line from the risk-free rate through the industry median — dots above it are stronger on a risk-adjusted basis.

Risk-Adjusted Metrics

AbbVie (ABBV) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: ABBVIndustry group median
Sharpe Ratio (1Y)1.500.81
Sortino Ratio (1Y)2.411.37

Profitability

ROE (TTM)

No usable ROE is available for AbbVie (ABBV) this period, so the shareholder-equity return read is skipped.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Group distribution
Max
99.40%
Q3
2.50%
Median
-31.42%
Q1
-62.21%
Min
-157.07%
ABBV
--
Largest peers
LLY
107.46%
NVO
71.40%
NVS
34.93%
AZN
23.48%
MRK
18.94%
ABBV
--
JNJ
--
Loading chart…
AbbVie (ABBV) doesn’t report ROE this period; the box shows the Pharmaceuticals, Biotechnology & Life Sciences group’s distribution and the dots its largest members.

Net Margin (TTM)

AbbVie (ABBV) keeps 5.79% of revenue as net profit, putting net margin in the upper peer quartile. After operating costs, interest, and taxes, more of each sales dollar reaches shareholders than it does at most industry peers.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.79%

Group distribution
Max
11.75%
ABBV
5.79%
Q3
2.69%
Median
0.00%
Q1
-3.38%
Min
-11.53%
Largest peers
NVO
37.21%
LLY
34.99%
NVS
23.92%
JNJ
21.48%
AZN
17.19%
MRK
13.59%
ABBV
5.79%
Loading chart…
Where AbbVie (ABBV) stands on net margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Operating Margin (TTM)

AbbVie (ABBV) turns 32.16% of revenue into operating profit, putting operating margin in the upper peer quartile. Before financing and taxes enter the picture, the day-to-day business keeps more of each sales dollar than most industry peers.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

32.16%

Group distribution
Max
100.30%
ABBV
32.16%
Q3
4.66%
Median
0.00%
Q1
-121.08%
Min
-309.54%
Largest peers
NVO
61.57%
LLY
49.39%
MRK
38.60%
ABBV
32.16%
NVS
30.48%
JNJ
28.61%
AZN
27.94%
Loading chart…
Where AbbVie (ABBV) stands on operating margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Profitability Metrics

AbbVie (ABBV) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: ABBVIndustry group median
ROE (TTM)---31.42%
ROA (TTM)10.03%-15.76%
Net Margin (TTM)5.79%0.00%
Operating Margin (TTM)32.16%0.00%
Gross Margin (TTM)72.03%30.12%

Growth

Revenue Growth

AbbVie (ABBV) grew revenue 8.57%, roughly around the peer group's normal range. Top-line momentum looks broadly typical for the industry.

Loading chart…
AbbVie (ABBV): Revenue Growth across different time periods, set against Pharmaceuticals, Biotechnology & Life Sciences industry-group medians.

EPS Growth

AbbVie (ABBV) grew earnings per share -1.26%, roughly around the peer group's normal range. Bottom-line momentum looks broadly typical for the industry.

Loading chart…
AbbVie (ABBV): EPS Growth across different time periods, set against Pharmaceuticals, Biotechnology & Life Sciences industry-group medians.

Growth Metrics

AbbVie (ABBV) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: ABBVIndustry group median
Revenue Growth (YoY)8.57%11.61%
Revenue Growth (3Y CAGR)1.75%10.74%
EPS Growth (YoY)-1.26%1.77%
EPS Growth (3Y CAGR)-29.13%3.04%

Financial Strength

Current Ratio (MRQ)

AbbVie (ABBV) has current ratio of 0.80, in the tighter-liquidity quartile for its industry. The short-term cushion is thinner than most peers carry, even if the absolute comfort level still depends on the business model.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.80

Group distribution
Max
26.16
Q3
12.33
Median
5.81
Q1
2.71
ABBV
0.80
Min
0.28
Largest peers
LLY
1.50
MRK
1.30
AZN
0.91
NVS
0.85
ABBV
0.80
NVO
0.79
JNJ
--
Loading chart…
Where AbbVie (ABBV) stands on current ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Debt / Equity (MRQ)

No usable debt-to-equity ratio is available for AbbVie (ABBV) this period, so the balance-sheet leverage read is skipped.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Group distribution
Max
1.60
Q3
0.68
Median
0.15
Q1
0.02
Min
0.00
ABBV
--
Largest peers
LLY
1.39
NVS
1.21
MRK
1.07
NVO
0.72
AZN
0.72
JNJ
0.68
ABBV
--
Loading chart…
AbbVie (ABBV) doesn’t report debt-to-equity ratio this period; the box shows the Pharmaceuticals, Biotechnology & Life Sciences group’s distribution and the dots its largest members.

Financial Strength Metrics

AbbVie (ABBV) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: ABBVIndustry group median
Current Ratio (MRQ)0.805.81
Debt / Equity (MRQ)--0.15
Net Debt / EBITDA2.121.05

Dividends

Dividend Yield (TTM)

AbbVie (ABBV) has dividend yield of 2.66%, above the entire industry range. That headline income is large, but yields this far above peers often come from a falling share price or an at-risk payout, so dividend safety matters more than the percentage itself.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.66%

Group distribution
ABBV
2.66%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Largest peers
NVO
23.58%
ABBV
2.66%
MRK
2.64%
JNJ
2.11%
AZN
1.95%
LLY
0.54%
NVS
0.00%
Loading chart…
Where AbbVie (ABBV) stands on dividend yield within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Payout Ratio (TTM)

AbbVie (ABBV) has payout ratio of 325.98%, meaning dividends exceeded current-period earnings. The gap would need to be covered by cash, retained earnings, financing, or other sources, so earnings alone do not support the payout.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

325.98%

Group distribution
ABBV
325.98%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Largest peers
ABBV
325.98%
MRK
93.52%
NVS
67.91%
JNJ
60.79%
AZN
47.70%
NVO
42.59%
LLY
22.13%
Loading chart…
Where AbbVie (ABBV) stands on payout ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Metrics

AbbVie (ABBV) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: ABBVIndustry group median
Dividend Yield (TTM)2.66%0.00%
Dividend Payout Ratio (TTM)325.98%0.00%

Valuation

P/E Ratio (TTM)

AbbVie (ABBV) trades at P/E ratio of 123.72, above the peer range for its industry. The market is paying unusually heavily for TTM earnings relative to comparable companies.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

123.72

Group distribution
ABBV
123.72
Max
79.93
Q3
47.39
Median
25.31
Q1
15.26
Min
2.05
Largest peers
ABBV
123.72
LLY
40.81
MRK
35.07
JNJ
28.91
AZN
24.76
NVS
21.40
NVO
11.90
Loading chart…
Where AbbVie (ABBV) stands on P/E ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

P/S Ratio (TTM)

AbbVie (ABBV) trades at 7.20 on P/S ratio, roughly in the peer group’s normal range. The market is not making a strong cheap-or-rich statement about its revenue base.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

7.20

Group distribution
Max
63.16
Q3
28.29
Median
8.07
ABBV
7.20
Q1
3.52
Min
0.01
Largest peers
LLY
14.51
ABBV
7.20
JNJ
6.16
NVS
5.17
MRK
4.74
AZN
4.35
NVO
0.67
Loading chart…
Where AbbVie (ABBV) stands on P/S ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

P/B Ratio (MRQ)

AbbVie (ABBV) has negative P/B ratio of -67.99, which means reported book equity is negative. Price-to-book breaks down in this situation and should not be used as a valuation signal.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

-67.99

Group distribution
Max
16.09
Q3
7.48
Median
3.80
Q1
1.72
Min
-5.70
ABBV
-67.99
Largest peers
LLY
33.66
NVS
7.62
JNJ
7.43
NVO
7.08
MRK
6.80
AZN
5.54
ABBV
-67.99
Loading chart…
Where AbbVie (ABBV) stands on P/B ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Valuation Metrics

AbbVie (ABBV) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: ABBVIndustry group median
P/E Ratio (TTM)123.7225.31
P/S Ratio (TTM)7.208.07
P/B Ratio (MRQ)-67.993.80
Free Cash Flow Yield (TTM)4.60%-2.02%